Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death

Norman M Kaplan

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Beta-adrenergic blocking agents are useful drugs in the treatment of hypertension. In multiple clinical trials, β blockers have been found to decrease the incidence of stroke and overall cardiovascular mortality. To provide maximal benefit, in particular, to blunt the early-morning surge in blood pressure associated with the increased circadian incidence of sudden cardiac death, the more cardioselective and longer-acting agents of this drug class are preferred.

Original languageEnglish (US)
Pages (from-to)20J-22J
JournalAmerican Journal of Cardiology
Volume80
Issue number9 B
DOIs
StatePublished - Nov 13 1997

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death'. Together they form a unique fingerprint.

Cite this